1. Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study. (July 2022) Authors: Leyvraz, Serge; Konietschke, Frank; Peuker, Caroline; Schütte, Moritz; Kessler, Thomas; Ochsenreither, Sebastian; Ditzhaus, Marc; Sprünken, Erin D.; Dörpholz, Gina; Lamping, Mario; Rieke, Damian T.; Klinghammer, Konrad; Burock, Susen; Ulrich, Claas; Poch, Gabriela; Schäfer, Reinhold; Klauschen, F... Journal: European journal of cancer Issue: Volume 169(2022) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative. Issue 3 (February 2015) Authors: Bogaerts, Jan; Sydes, Matthew R.; Keat, Nicola; McConnell, Andrea; Benson, Al; Ho, Alan; Roth, Arnaud; Fortpied, Catherine; Eng, Cathy; Peckitt, Clare; Coens, Corneel; Pettaway, Curtis; Arnold, Dirk; Hall, Emma; Marshall, Ernie; Sclafani, Francesco; Hatcher, Helen; Earl, Helena; Ray-Coquard, Isab... Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTNI-04. ACTIVITY OF LAROTRECTINIB IN TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) METASTASES. (9th November 2020) Authors: Patel, Jyoti D; Farago, Anna F; Hong, David S; Lassen, Ulrik N; Leyvraz, Serge; Park, Keunchil; Sohal, Davendra P S; Solomon, Benjamin; Reeves, John A; Dima, Laura; Brega, Nicoletta; Drilon, Alexander Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of computerisation on the quality and safety of chemotherapy prescription. Issue 6 (1st December 2006) Authors: Voeffray, Marc; Pannatier, André; Stupp, Roger; Fucina, Nadia; Leyvraz, Serge; Wasserfallen, Jean-Blaise Journal: Quality & safety in health care Issue: Volume 15:Issue 6(2006) Page Start: 418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma. Issue 6 (29th April 2022) Authors: Waguespack, Steven G; Drilon, Alexander; Lin, Jessica J; Brose, Marcia S; McDermott, Ray; Almubarak, Mohammed; Bauman, Jessica; Casanova, Michela; Krishnamurthy, Anuradha; Kummar, Shivaani; Leyvraz, Serge; Oh, Do-Youn; Park, Keunchil; Sohal, Davendra; Sherman, Eric; Norenberg, Ricarda; Silvertown... Journal: European journal of endocrinology Issue: Volume 186:Issue 6(2022) Page Start: 631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion–Positive Lung Cancers. (27th January 2022) Authors: Drilon, Alexander; Tan, Daniel S. W.; Lassen, Ulrik N.; Leyvraz, Serge; Liu, Yongmei; Patel, Jyoti D.; Rosen, Lee; Solomon, Benjamin; Norenberg, Ricarda; Dima, Laura; Brega, Nicoletta; Shen, Lin; Moreno, Victor; Kummar, Shivaani; Lin, Jessica J. Journal: JCO precision oncology Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long‐term outcome of dasatinib first‐line treatment in gastrointestinal stromal tumor: A multicenter, 2‐stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07). Issue 7 (9th January 2018) Authors: Montemurro, Michael; Cioffi, Angela; Dômont, Julien; Rutkowski, Piotr; Roth, Arnaud D.; von Moos, Roger; Inauen, Roman; Toulmonde, Maud; Burkhard, Roger O.; Knuesli, Claudio; Bauer, Sebastian; Cassier, Philippe; Schwarb, Heike; Le Cesne, Axel; Koeberle, Dieter; Bärtschi, Daniela; Dietrich, Daniel... Journal: Cancer Issue: Volume 124:Issue 7(2018) Page Start: 1449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients. (2nd January 2017) Authors: Rusakiewicz, Sylvie; Perier, Aurélie; Semeraro, Michaela; Pitt, Jonathan M.; Pogge von Strandmann, Elke; Reiners, Katrin S.; Aspeslagh, Sandrine; Pipéroglou, Christelle; Vély, Frédéric; Ivagnes, Alexandre; Jegou, Sarah; Halama, Niels; Chaigneau, Loic; Validire, Pierre; Christidis, Christos; Perni... Journal: Oncoimmunology Issue: Volume 6:Number 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours. (15th March 2013) Authors: Haouala, Amina; Widmer, Nicolas; Guidi, Monia; Montemurro, Michael; Leyvraz, Serge; Buclin, Thierry; Eap, Chin B.; Decosterd, Laurent A.; Csajka, Chantal Journal: British journal of clinical pharmacology Issue: Volume 75:Number 4(2013:Apr.) Page Start: 1007 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Radiotherapy for GIST progressing during or after tyrosine kinase inhibitor therapy: A prospective study. Issue 2 (August 2015) Authors: Joensuu, Heikki; Eriksson, Mikael; Collan, Juhani; Balk, Marja H.; Leyvraz, Serge; Montemurro, Michael Journal: Radiotherapy and oncology Issue: Volume 116:Issue 2(2015:Aug.) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗